Ad is loading...
MENU
LYRA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lyra Therapeutics (LYRA) Earnings Date & Reports

A.I. Advisor
published Earnings

LYRA is expected to report earnings to rise 6.94% to -19 cents per share on March 05

Lyra Therapeutics LYRA Stock Earnings Reports
Q4'24
Est.
$-0.19
Q3'24
Beat
by $0.04
Q2'24
Missed
by $0.41
Q1'24
Missed
by $0.09
Q4'23
Beat
by $0.13
The last earnings report on November 12 showed earnings per share of -18 cents, beating the estimate of -21 cents. With 1.90M shares outstanding, the current market capitalization sits at 12.37M.
View a ticker or compare two or three
LYRA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage therapeutics company, which develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 393-4600
Employees
145
Web
https://lyratherapeutics.com